- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 9/12 - Antihypertensives
Patent holdings for IPC class A61P 9/12
Total number of patents in this class: 4033
10-year publication summary
|
126
|
107
|
170
|
239
|
216
|
222
|
244
|
256
|
233
|
166
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Daiichi Sankyo Company, Limited | 1886 |
70 |
| Novartis AG | 10725 |
69 |
| Takeda Pharmaceutical Company Limited | 2706 |
55 |
| Actelion Pharmaceuticals Ltd | 528 |
40 |
| Sunshine Lake Pharma Co., Ltd. | 599 |
37 |
| Mitsubishi Tanabe Pharma Corporation | 582 |
34 |
| United Therapeutics Corporation | 309 |
34 |
| Taisho Pharmaceutical Co., Ltd. | 865 |
30 |
| Acceleron Pharma Inc. | 358 |
28 |
| F. Hoffmann-La Roche AG | 7947 |
25 |
| Boehringer Ingelheim Vetmedica GmbH | 1276 |
25 |
| Shionogi & Co., Ltd. | 848 |
24 |
| Bayer Pharma AG | 1054 |
21 |
| Dainippon Sumitomo Pharma Co., Ltd. | 184 |
20 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 180 |
20 |
| Nippon Shinyaku Co., Ltd. | 322 |
20 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3183 |
20 |
| Regeneron Pharmaceuticals, Inc. | 4335 |
19 |
| Mayo Foundation for Medical Education and Research | 3245 |
18 |
| Janssen Pharmaceutica N.V. | 3362 |
17 |
| Other owners | 3407 |